Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-05
2007-06-05
McKenzie, Thomas (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S357000, C546S329000, C546S255000, C546S257000
Reexamination Certificate
active
10470786
ABSTRACT:
A zinc(II) complex which is lowly toxic, has high insulin-like activity, and is effectively usable as a hypoglycemic agent for the prevention or treatment of diabetes; a hypoglycemic agent containing the complex; a medicinal preparation which contains the complex and is useful as a preventive/remedy for diabetes; and a food containing the complex, such as a health food or supplementary health food. The hypoglycemic agent contains an organic zinc(II) complex having as a ligand a compound selected among aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, α- and β-hydroxycarboxylic acids, vitamins, glutamine derivatives, etc.
REFERENCES:
patent: 5948388 (1999-09-01), Steele et al.
patent: 5962517 (1999-10-01), Murad
patent: 2005/0130880 (2005-06-01), Kojima et al.
patent: 2013426 (1971-10-01), None
patent: 2226267 (1973-12-01), None
patent: 2457524 (1976-06-01), None
patent: 29701214 (1997-03-01), None
patent: 0 256 645 (1988-02-01), None
patent: 0 658 568 (1995-06-01), None
patent: 0 755 917 (1997-01-01), None
patent: 53-38630 (1978-04-01), None
patent: 54-55712 (1979-05-01), None
patent: 61-282317 (1986-12-01), None
patent: 6-1720 (1994-01-01), None
patent: WO-79/00435 (1979-07-01), None
patent: WO 87/01281 (1987-03-01), None
patent: WO-87/01281 (1987-03-01), None
patent: WO 87/04622 (1987-08-01), None
patent: WO-99/07224 (1999-02-01), None
patent: WO 01/39769 (2001-06-01), None
Hcaplus 91:48687.
Hcaplus 78:10.
Hcaplus 128:18742.
pubMed ID: 15301787.
International Search Report.
I. Hwang et al.,Diabetes Obes Metab, 5(5): pp. 317-324 Abstract Only t (2003).
M.J. Rosenthal et al.,Life Sciences, vol. 70, pp. 337-348 (2001).
M.K. Song et al.,Metabolism, vol. 47, No. 1, pp. 39-43 (1998).
M.K. Song et al.,Metabolism, vol. 50, No. 1, pp. 53-59, (2001).
S.R. Narad et al.,Indian Journal of Experimental Biology, vol. 34, pp. 81-82, (1996).
A. Abufarag et al.,Inorganic Chemistry, 34(8):2207-2216 (1995).
H. Hemmerle et al.,Journal of Medicinal Chemistry, 40(2):137-145 (1997).
Kojima Yoshitane
Sakurai Hiromu
Yoshikawa Yutaka
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Japan Science and Technology Corporation
McKenzie Thomas
O'Day Christine C.
LandOfFree
Hypoglycemic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3830726